The pharmaceutical industry as a political player
- 1 November 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9344), 1498-1502
- https://doi.org/10.1016/s0140-6736(02)11477-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Industry-sponsored clinical research: a double-edged swordThe Lancet, 2001
- The FDA and The Lancet : an exchangeThe Lancet, 2001
- Lessons from the glitazones: a story of drug developmentThe Lancet, 2001
- Trading risks for markets: The international harmonisation of pharmaceuticals regulationHealth, Risk & Society, 2001
- Academia and industryThe Lancet, 2000
- Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?Social Science & Medicine, 1999
- Democracy, Technocracy, and the Secret State of Medicines Control: Expert and Nonexpert PerspectivesScience, Technology, & Human Values, 1997
- Population Exposure Required to Assess Clinical Safety: Report to the International Conference on Harmonization Working GroupDrug Information Journal, 1996
- The Drug Lag Issue: The Debate Seen from an International PerspectiveInternational Journal of Health Services, 1992
- New procedures affecting the conduct of clinical trials in the United Kingdom.BMJ, 1981